Literature DB >> 3535925

Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease.

J H Butterfield, G M Kephart, P M Banks, G J Gleich.   

Abstract

Lymph nodes from each of the four histologic types of Hodgkin's disease were examined for the presence of eosinophils and for eosinophil degranulation by immunofluorescent localization of eosinophil granule major basic protein (MBP). Eosinophil degranulation shown by MBP deposition outside of eosinophils was found in six of eight nodes from patients with nodular sclerosing disease and in two of eight nodes from patients with lymphocyte depletion-type disease. Three nodes of the mixed cellularity type, one node of the lymphocyte predominance type, and one lymph node of the lymphocyte depletion type showed one or two small foci of extracellular MBP deposition. Lymph nodes from patients without Hodgkin's disease showed no extracellular deposition of MBP. Large numbers of eosinophils were found in seven of eight nodes of the nodular sclerosing variant, but were less frequently seen among the other types of Hodgkin's disease. The presence of extracellular MBP in lymph nodes of patients with Hodgkin's disease indicates that eosinophil degranulation commonly occurs and suggests that the released eosinophil granule proteins may participate in the inflammatory reaction in this disorder more extensively than is presently appreciated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3535925

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas.

Authors:  M K Samoszuk; V Nguyen; I Gluzman; J H Pham
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

2.  Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta).

Authors:  F Levi-Schaffer; E Garbuzenko; A Rubin; R Reich; D Pickholz; P Gillery; H Emonard; A Nagler; F A Maquart
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

3.  Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.

Authors:  H Noguchi; G M Kephart; T V Colby; G J Gleich
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

4.  Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease.

Authors:  M Kadin; J Butmarc; A Elovic; D Wong
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

5.  Vesicle-mediated secretion of human eosinophil granule-derived major basic protein.

Authors:  Rossana C N Melo; Lisa A Spencer; Sandra A C Perez; Josiane S Neves; Staci P Bafford; Ellen S Morgan; Ann M Dvorak; Peter F Weller
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

6.  Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors.

Authors:  Sonja C S Simon; Xiaoying Hu; Jasper Panten; Mareike Grees; Simon Renders; Daniel Thomas; Rebekka Weber; Torsten J Schulze; Jochen Utikal; Viktor Umansky
Journal:  Oncoimmunology       Date:  2020-02-15       Impact factor: 8.110

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.